RecruitingPhase 4NCT07512635

Effect of Intercostal Nerve Block With Liposomal Bupivacaine on Quality of Recovery in VATS Partial Pneumonectomy

Effect of Intercostal Nerve Block With Liposomal Bupivacaine on Postoperative Quality of Recovery in Patients Undergoing Video-assisted Thoracoscopic Partial Pneumonectomy


Sponsor

Sanming First Hospital

Enrollment

96 participants

Start Date

Apr 6, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Video-assisted thoracoscopic surgery (VATS) is a minimally invasive approach for partial pneumonectomy, but postoperative pain remains a major challenge affecting recovery. Intercostal nerve block (ICNB) with conventional local anesthetics provides limited duration of analgesia, often insufficient to cover the peak pain period after surgery. Liposomal bupivacaine is a long-acting formulation designed to provide extended analgesia up to 72 hours. This study aims to evaluate the effect of preoperative ICNB with liposomal bupivacaine compared with conventional bupivacaine hydrochloride on postoperative quality of recovery in patients undergoing VATS partial pneumonectomy. The primary outcome is the Quality of Recovery-15 (QoR-15) score at 24 hours postoperatively. We hypothesize that liposomal bupivacaine ICNB results in superior recovery quality compared with conventional bupivacaine, with reduced postoperative pain and opioid consumption.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria3

  • Patients scheduled for thoracic surgery under general anesthesia via thoracoscopic approach;
  • Age 18-65 years;
  • Classified as Grade I-II by the American Society of Anesthesiologists (ASA).

Exclusion Criteria5

  • History of local anesthetic allergy.
  • Chronic opioid users.
  • Contraindications for nerve block, including infection at the puncture site and coagulation disorders;
  • Language communication impairment.
  • Other conditions unsuitable for inclusion in the trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGBupivacaine Hydrochloride

Single-dose, pre-procedural intercostal nerve block with bupivacaine hydrochloride, administered by thoracoscopy prior to surgery.

DRUGBupivacaine liposome

Single-dose, pre-procedural intercostal nerve block with bupivacaine liposome, administered by thoracoscopy prior to surgery.


Locations(1)

SanMing First Hospital

Sanming, Fujian, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07512635


Related Trials